Home › Funds › Nicholas Investment Partners, LP › AXSM

Nicholas Investment Partners, LP position in AXSM

AXSOME THERAPEUTICS INC. · Health Care

Nicholas Investment Partners, LP reported holding 72,060 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$13.3M, representing 0.99% of its reported portfolio and ranking #31 among its reported holdings. Nicholas Investment Partners, LP has disclosed AXSM holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)72.06K sh
Reported value held$13.29M
Portfolio Weight0.99%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Nicholas Investment Partners, LP's AXSM position evolved

Nicholas Investment Partners, LP first disclosed a stake in AXSM in Q3 2023 at 394,980 shares (US$27.6M). Across 12 filings, Nicholas Investment Partners, LP increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 72,060 shares valued at US$13.3M — a reduction of -26,914 shares quarter over quarter.. Notable position changes include a 79% trim in Q4 2023 (shares were roughly flat over the following quarter), a 330% increase in Q1 2025 (shares fell 10% over the following quarter), a 88% increase in Q4 2025 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 394.98K $27.61M New
Q4 2023 82.64K $6.58M Reduce
Q1 2024 36.82K $2.94M Reduce
Q3 2024 10.13K $910.83K New
Q4 2024 10.13K $857.52K Hold
Q1 2025 43.57K $5.08M Add
Q2 2025 42.15K $4.40M Reduce
Q3 2025 48.66K $5.91M Add
Q4 2025 91.56K $16.72M Add
Q1 2026 81.48K $13.77M Reduce
Q2 2026 98.97K $24.23M Add
Q3 2026 72.06K $13.29M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AXSM and 13F data

AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 43 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$147.5M), ALETHEA CAPITAL MANAGEMENT, LLC (US$119.7M), Sofinnova Investments, Inc. (US$82.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AXSM

All AXSM fund holders →

FAQ

How long has Nicholas Investment Partners, LP held AXSM?

Nicholas Investment Partners, LP has disclosed AXSM holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Nicholas Investment Partners, LP's current position in AXSM?

As of Q3 2026, Nicholas Investment Partners, LP holds 72.06K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $13.29M, representing 0.99% of its reported portfolio and ranking #31.

Has Nicholas Investment Partners, LP been buying or selling AXSM?

In the latest 13F filing (Q3 2026), Nicholas Investment Partners, LP reduced its position in AXSM.

Which other funds hold AXSM?

Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Sofinnova Investments, Inc., among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.